Search

everythinglearnresearchcommunity

for

Search:↓

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Zinc can help with some skin problems, but its effectiveness varies depending on the condition.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Sex hormones affect brain injury differently in males and females.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Olive leaf compound oleuropein helps grow hair in mice.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.